DRTS - Alpha Tau Medical Ltd.

QQQ $ 629.16 $ 3.02 (0.48 %)

DIA $ 475.58 $ 0.66 (0.14 %)

SPY $ 681.80 $ 2.23 (0.33 %)

TLT $ 90.21 $ -0.27 (-0.3 %)

GLD $ 368.20 $ -2.01 (-0.54 %)

Previous Close

$ 4.165

Open

$ 4.05

Bid

$ 3.70 x 50

Ask

$ 4.42 x 20

Day's Range

$ 3.89 - $ 4.21

52 Week Range

$ 2.14 - $ 4.69

Volume

79,923

Average Volume

Market Cap

290.18M

Beta (5Y Monthly)

$ 1.16

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type	Report Link
No Data found

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

HC Wainwright & Co. Reiterates Buy on Alph...
10/22/2025 14:40:49

HC Wainwright & Co. analyst Yi Chen reiterates Alpha Tau Medical (NASDAQ:DRTS) with a Buy and maintains $9 price target.

12 Health Care Stocks Moving In Wednesday'...
10/22/2025 12:09:33

Alpha Tau Receives Radioactive Material Li...
10/21/2025 12:32:35

HC Wainwright & Co. Reiterates Buy on Alph...
09/03/2025 10:58:14

HC Wainwright & Co. analyst Yi Chen reiterates Alpha Tau Medical (NASDAQ:DRTS) with a Buy and maintains $9 price target.

Alpha Tau Medical Q2 EPS $(0.13) Misses $(...
08/11/2025 21:26:18

Alpha Tau Medical (NASDAQ:DRTS) reported quarterly losses of $(0.13) per share which missed the analyst consensus estimate of $...

Alpha Tau Medical 1H EPS $(0.25)
08/11/2025 20:19:50

Alpha Tau Medical Q1 EPS $(0.12) Beats $(0...
05/19/2025 20:02:33

Alpha Tau Medical (NASDAQ:DRTS) reported quarterly losses of $(0.12) per share which beat the analyst consensus estimate of $(0...

HC Wainwright & Co. Reiterates Buy on Alph...
04/29/2025 13:26:53

HC Wainwright & Co. analyst Yi Chen reiterates Alpha Tau Medical (NASDAQ:DRTS) with a Buy and maintains $9 price target.

Oramed Pharma Closes Strategic Investment ...
04/28/2025 13:04:26

Alpha Tau Medical Ltd. ("Alpha Tau", or the "Company") (NASDAQ:DRTS, DRTSW))), the developer of the innovative ...

Alpha Tau Granted FDA Approval To Initiate...
04/02/2025 12:32:33

JERUSALEM, April 02, 2025 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. (NASDAQ:DRTS, DRTSW))), the developer of the innovative al...

HC Wainwright & Co. Reiterates Buy on Alph...
03/17/2025 15:06:45

HC Wainwright & Co. analyst Yi Chen reiterates Alpha Tau Medical (NASDAQ:DRTS) with a Buy and maintains $9 price target.

Alpha Tau Receives Medical Device Single A...
02/24/2025 13:33:22

Alpha Tau Medical Ltd. ("Alpha Tau", or the "Company") (NASDAQ:DRTS, DRTSW))), the developer of the innovative ...

Alpha Tau Receives FDA Approval For IDE Su...
02/03/2025 13:32:05

Alpha Tau Announces Upcoming Presentation ...
12/18/2024 13:42:40

Alpha Tau Medical Ltd. ("Alpha Tau", or the "Company") (NASDAQ:DRTS, DRTSW))), the developer of the innovative ...

HC Wainwright & Co. Reiterates Buy on Alph...
11/22/2024 09:53:36

HC Wainwright & Co. analyst Yi Chen reiterates Alpha Tau Medical (NASDAQ:DRTS) with a Buy and maintains $9 price target.

Alpha Tau Medical Q3 EPS $(0.10) Beats $(0...
11/20/2024 15:07:10

Alpha Tau Medical (NASDAQ:DRTS) reported quarterly losses of $(0.10) per share which beat the analyst consensus estimate of $(0...

HC Wainwright & Co. Reiterates Buy on Alph...
10/23/2024 09:49:54

HC Wainwright & Co. analyst Yi Chen reiterates Alpha Tau Medical (NASDAQ:DRTS) with a Buy and maintains $9 price target.

Alpha Tau Medical Accepted Into FDA's Tota...
10/21/2024 12:32:35

HC Wainwright & Co. Reiterates Buy on Alph...
10/11/2024 10:54:30

HC Wainwright & Co. analyst Yi Chen reiterates Alpha Tau Medical (NASDAQ:DRTS) with a Buy and maintains $9 price target.

Alpha Tau Treats First Patient with Recurr...
10/10/2024 12:36:45

Alpha Tau Medical Ltd. ("Alpha Tau", or the "Company") (NASDAQ:DRTS, DRTSW)))), the developer of the innovative...